Cancer - Arcellx, Inc.
Cancer
Status:
Active, open to accrualClinicalTrials.gov:
NCT05396885A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma